Frameworks for Digital Advertising
Standards in Medicine.

China · Advertising framework

Radio spots and spoken promotions for pharmacies and health retail in China

General market orientation, not campaign clearance. Research scope and dates

Product and service rules

Separate prescription sales controls from advertising permission

Regulator guidance

The online-sales rules require prescription and non-prescription products to be displayed separately. Prescription pages need the specified risk notice; prescription-sales home/main pages must not directly display packaging and labels, and before prescription review the retailer must not provide the purchase service or display leaflet information. A lawful retail listing process does not override the separate restrictions on prescription-drug advertising.

Sources: Online medicine sales supervision measures

Channel rules

Check the complete consumer-facing message

Regulator guidance

Advertising must be truthful and clear. Review the accuracy of stated functions, benefits, provider details, prices and promises under the Advertising Law. Sector review requirements and prohibited claims continue to apply even when the advertiser identifies the commercial nature of a message.

Sources: Advertising Law of the People’s Republic of China

Do not apply the ordinary-data threshold to health data

Regulator guidance

The CAC identifies medical and health information as sensitive personal information. Its under-100,000-person ordinary-data exemption excludes sensitive data. Subject to stated exemptions, a non-critical-infrastructure operator exporting sensitive information for fewer than 10,000 people must use the standard-contract or certification route; at least 10,000 requires a security assessment. Important data and critical-infrastructure operators have separate assessment triggers. Count people from 1 January and document the specific exemption, if any; an advertising consent checkbox does not establish a transfer mechanism.

Sources: Cross-border data provisions — official explanatory FAQ

Review the audio without visual support

Editorial recommendation

Check product eligibility and applicable radio requirements. Listen at normal speed to the whole spot, including warnings and sponsorship language. A website address does not automatically replace spoken mandatory information.

Campaign workflow

Pharmacies & Health Retail: prepare the review

Editorial recommendation

Separate promotion of the pharmacy from advertising of each medicine or other product. Verify online-supply and delivery permissions independently of advertising eligibility. Review price promotions and inducements under both retail and medicine rules.

Keep a traceable campaign decision

Editorial recommendation

Keep one review record linking the offer, local market status, claim evidence, exact creative, media settings and any regulatory or professional clearance. Record who checked each condition. Reopen the review when the offer, claim, source rule or execution changes.

Pre-publication checklist

  • Separate promotion of the pharmacy from advertising of each medicine or other product.
  • Verify online-supply and delivery permissions independently of advertising eligibility.
  • Review price promotions and inducements under both retail and medicine rules.
  • Record product or provider eligibility before approving claims.
  • Archive the final creative and its evidence, permissions and review decisions.
  • Assign an owner for source updates, complaints and prompt withdrawal of inaccurate material.

Scope and unresolved questions

  • Mainland only. Beijing TCM review, national online-retail display conditions, warning presentation and a cross-border data route are documented. Other provincial filing procedures, actual seller permissions, platform account rules, product-specific Chinese assets and the transfer facts still require review.
  • This national baseline does not review every broadcaster rule, platform policy, regional licensing condition, promotion mechanic or data-transfer arrangement. No format-specific warning dimensions or durations should be inferred where none are supplied.
Research scope, introduction and dates

Pharmacy promotion in radio spots in China needs separate decisions about the retailer, the advertised products and any online supply. Use this guide to keep medicine restrictions, seller permissions and promotional price mechanics in the same review.

A radio spot must communicate its meaning without supporting visuals. Listen to the final voiceover at ordinary playback speed and allow enough airtime for the information and any warning applicable to the advertised offer.

Sources checked 2026-10-24 · Editorial research · Legal review pending

General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.

Coverage: National baseline and category-specific review routes; not an exhaustive compliance opinion

How to use this national baseline

Editorial overview

This framework combines researched national rules with editorial review steps. Mainland China only; Hong Kong, Macau and Taiwan are outside this pack. A visible channel workflow does not establish that the selected product or service may be advertised there. Read the category restrictions first.

The review date identifies when the cited provisions or regulator excerpts were checked. It does not mean that every local rule, exception, professional standard or platform policy has been reviewed.

Your next step: choose a local partner

Use this framework to brief qualified local legal and regulatory specialists. Ask them to verify current requirements and assess your specific product, service and campaign before acting.

Sources

  1. Advertising Law of the People’s Republic of China

    SAMR · legislation · checked 2026-10-24

    Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.

  2. Cross-border data provisions — official explanatory FAQ

    Cyberspace Administration of China · regulator guidance · checked 2026-10-25

    Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.

  3. Online medicine sales supervision measures

    NMPA Information Center / SAMR · legislation · checked 2026-10-25

    Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.

From framework to action

Local expertise in China

Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in China.

Medical & health marketing

No partners listed in this category yet.

Marketing & sales advisory

No partners listed in this category yet.

Business & project coordination

No partners listed in this category yet.

Browse partners in China

Join the local partner directory

Would you like your company to be listed?

Talk to us about the terms of a listing. Leave your details and we will get in touch.

Publicity@fdasm.com

Contact details for a partner listing enquiry

We use your details to respond to your enquiry and discuss a listing. Submitting the form does not automatically add your company to the directory. Read our Privacy & cookies policy. Privacy contact: Publicity@fdasm.com.